8-K//Current report
ABVC BIOPHARMA, INC. 8-K
Accession 0001213900-25-104900
$ABVCCIK 0001173313operating
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 7:30 AM ET
Size
347.7 KB
Accession
0001213900-25-104900
Documents
- 8-Kea0263481-8k_abvcbio.htmPrimary
CURRENT REPORT
- EX-99.1ea026348101ex99-1_abvcbio.htm
PRESS RELEASE
- GRAPHICex99-1_001.jpg
GRAPHIC
- EX-101.SCHabvc-20251103.xsd
XBRL SCHEMA FILE
- EX-101.LABabvc-20251103_lab.xml
XBRL LABEL FILE
- EX-101.PREabvc-20251103_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-104900-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0263481-8k_abvcbio_htm.xml
IDEA: XBRL DOCUMENT
Issuer
ABVC BIOPHARMA, INC.
CIK 0001173313
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001173313
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 7:30 AM ET
- Size
- 347.7 KB